CRISTINA HODGKISS: Open Payments
NPI 1528389558 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 14 payments from 5 companies in 2025. Trend: 2023 $149 · 2024 $332 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $154 |
| Alnylam Pharmaceuticals Inc. | 3 | $110 |
| Medtronic, Inc. | 1 | $109 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
| GE HEALTHCARE | 1 | $14 |
Products named: Ozempic, COREVALVE EVOLUT R, ONPATTRO, LEQVIO, AMVUTTRA.
Industry payments across TX — which companies pay providers there.
